CMS Examines Coverage Options for HIV PrEP Preventative Care

A new analysis has been launched by the US Centers for Medicare and Medicaid Services (CMS) to evaluate the nationwide coverage of HIV preexposure prophylaxis (PrEP), a group of antiretroviral drugs that prevent HIV infections and transmission when taken appropriately. The drugs, which hover at around $2300 a year, fall under Medicare coverage for some states but not all.

According to Zachary Brennan, “The decision from CMS to open this analysis comes as the US Preventive Services Task Force recently updated a 2019 recommendation and offered a grade A last month for prescribing PrEP with effective antiretroviral therapy to persons who are at increased risk of HIV.”

To read more, click here.

(Source: Endpoints News, January 17^th, 2023)